Rchr
J-GLOBAL ID:200901040594980956   Update date: May. 26, 2010

Tanaka Motoyoshi

タナカ モトヨシ | Tanaka Motoyoshi
Affiliation and department:
Job title: 部長
Research field  (2): Urology ,  Medical biochemistry
Research keywords  (3): 腎尿路生殖器 ,  腫瘍学 ,  Urologic Oncology
Research theme for competitive and other funds  (2):
  • 2002 - Molecalav Approach of Urologic Oncology
  • 泌尿器腫瘍に対する分子生物学的研究
MISC (6):
  • Connexin 26 Enhanced the Bystander Effect in HSVtk/GCD Gene Therapy for Human Bladder Cancer by Adenovirus /PLL/DNA Gene Delivery. Gene Therapy. 2001. 8, 139-148
  • Connexin 26 Gene Therapy of Human Bladder Cancer: Induction of Growth Suppression, Apoptosis, and Synagy with Cisplatin. Human Gene therapy. 2001. 12, 2225-2236
  • Connexin 26 Enhanced the Bystander Effect in HSVtk/GCD Gene Therapy for Human Bladder Cancer by Adenovirus /PLL/DNA Gene Delivery. Gene Therapy. 2001. 8, 139-148
  • Connexin 26 Gene Therapy of Human Bladder Cancer: Induction of Growth Suppression, Apoptosis, and Synagy with Cisplatin. Human Gene therapy. 2001. 12, 2225-2236
  • MUACI/PTEN Inhabits Cell Growth and Induces Chemosensitivity to Dexcrabicin in Human Bladder Cancer Cells. Oncogene. 2000. 19, 5406-5412
more...
Education (2):
  • - 1997 Hokkaido University
  • - 1988 Asahikawa Medical University Medical Course
Professional career (1):
  • Doctor of Medical Science (Hokkaido University)
Work history (2):
  • 1997 - 2002 米国テキサス大学MDアンダーソン癌センター***
  • 1997 - 2002 UT MD Anderson Cancer Center **********
Awards (2):
  • 2000 - 日本泌尿器科学会賞
  • 2000 - Japanese Urologic Association Award
Association Membership(s) (3):
日本解剖学会 ,  日本泌尿器科学会 ,  Japanese Urological Association
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page